Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01575028 |
Recruitment Status :
Terminated
(The study was allowed to expire due to changes in standard care for the patient population within the NCH institution.)
First Posted : April 10, 2012
Results First Posted : June 1, 2015
Last Update Posted : August 24, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Triple (Participant, Care Provider, Outcomes Assessor); Primary Purpose: Treatment |
Condition |
Appendicitis |
Interventions |
Drug: Ropivacaine Drug: Bupivacaine |
Enrollment | 3 |
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | Local Anesthetic Infiltration Injection | Transversus Abdominis Plane (TAP) Block |
---|---|---|
![]() |
Patients will receive local anesthetic infiltration injected at the surgical site by the surgeon at the end of surgery. Bupivacaine: The local anesthetic at the incision sites will be injected by the surgeon. |
Patients will receive a transversus abdominis plane (TAP) block. Ropivacaine: The TAP block will be delivered with 0.2ml/kg of 0.2% Ropivacaine with 1:200,000 epinephrine bilaterally |
Period Title: Overall Study | ||
Started | 2 | 1 |
Completed | 2 | 0 |
Not Completed | 0 | 1 |
Reason Not Completed | ||
Physician Decision | 0 | 1 |
Arm/Group Title | Local Anesthetic Infiltration Injection | Transversus Abdominis Plane (TAP) Block | Total | |
---|---|---|---|---|
![]() |
Patients will receive local anesthetic infiltration injected at the surgical site by the surgeon at the end of surgery. Bupivacaine: The local anesthetic at the incision sites will be injected by the surgeon. |
Patients will receive a transversus abdominis plane (TAP) block. Ropivacaine: The TAP block will be delivered with 0.2ml/kg of 0.2% Ropivacaine with 1:200,000 epinephrine bilaterally |
Total of all reporting groups | |
Overall Number of Baseline Participants | 2 | 1 | 3 | |
![]() |
[Not Specified]
|
|||
Age, Categorical
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 2 participants | 1 participants | 3 participants | |
<=18 years |
2 100.0%
|
1 100.0%
|
3 100.0%
|
|
Between 18 and 65 years |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
>=65 years |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Age, Continuous
Mean (Standard Deviation) Unit of measure: Years |
||||
Number Analyzed | 2 participants | 1 participants | 3 participants | |
13.425 (4.871965722) | 7.36 (0) | 11.40 (4.91) | ||
Sex: Female, Male
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 2 participants | 1 participants | 3 participants | |
Female |
0 0.0%
|
1 100.0%
|
1 33.3%
|
|
Male |
2 100.0%
|
0 0.0%
|
2 66.7%
|
|
Race (NIH/OMB)
Measure Type: Count of Participants Unit of measure: Participants |
||||
Number Analyzed | 2 participants | 1 participants | 3 participants | |
American Indian or Alaska Native |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Asian |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Native Hawaiian or Other Pacific Islander |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Black or African American |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
White |
2 100.0%
|
1 100.0%
|
3 100.0%
|
|
More than one race |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Unknown or Not Reported |
0 0.0%
|
0 0.0%
|
0 0.0%
|
|
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||||
United States | Number Analyzed | 2 participants | 1 participants | 3 participants |
2 | 1 | 3 |
Name/Title: | Tarun Bhalla |
Organization: | Nationwide Children's Hospital |
Phone: | (614) 722-4200 |
EMail: | Tarun.Bhalla@NationwideChildrens.org |
Responsible Party: | Tarun Bhalla, MD, Nationwide Children's Hospital |
ClinicalTrials.gov Identifier: | NCT01575028 |
Other Study ID Numbers: |
IRB12-00140 |
First Submitted: | April 5, 2012 |
First Posted: | April 10, 2012 |
Results First Submitted: | May 14, 2015 |
Results First Posted: | June 1, 2015 |
Last Update Posted: | August 24, 2015 |